Congress 116 - S 2032 - Cannabidiol and Marihuana Research Expansion Act

Sponsor

Cosponsors

Topics

Congressional oversight Crime and Law Enforcement Drug safety, medical device, and laboratory regulation Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Health personnel Health programs administration and funding Licensing and registrations Medical research Public-private cooperation Research administration and funding Trade restrictions

Full Text

View Full Bill Text

Votes

Summary

Cannabidiol and Marihuana Research Expansion Act

This bill modifies provisions concerning the federal regulation of certain drugs that are deemed to pose a risk of abuse and dependence to facilitate research on, and the use of, medical treatments containing marijuana and its derivatives.

Actions

Dec 16, 2020

Held at the desk.
Dec 16, 2020

Received in the House.
Dec 16, 2020

Message on Senate action sent to the House.
Dec 15, 2020

Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7504-7507)
Dec 15, 2020

Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.(text of amendment in the nature of a substitute: CR S7504-7507)
Dec 15, 2020

Measure laid before Senate by unanimous consent. (consideration: CR S7508)
Dec 15, 2020

Senate Committee on the Judiciary discharged by Unanimous Consent.
Oct 23, 2019

Committee on United States Senate Caucus on International Narcotics Control. Hearings held. Hearings printed: S.Hrg. 116-252.
Jun 27, 2019

Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S4633-4634)
Jun 27, 2019

Introduced in Senate

Amendments

Related Bills